Skip to main content
INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance

6 x PhD Studentships with the INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance

INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance

The INEOS Oxbridge Doctoral Initiative is a programme that integrates the expertise and capabilities of two Universities that are globally recognised for excellence in health science research. This is funded by the INEOS Oxford Institute, with studentships fully funded for 3.5 years (fixed term).

Three studentships will be awarded in Oxford (DPhil) and three will be awarded in Cambridge (PhD), but students will be encouraged to train in both Universities. This provides the chance to experience the best of both academic environments and their established networks.

At the heart of the initiative is an ambition to nurture a diverse cohort of outstanding young scientists who will become equipped to deal with the global challenges posed by the rapidly emerging threat from antimicrobial resistance. Brief details of the projects, main base and supervisors are given below.

Six fully funded PhD/DPhil studentships available to start in October 2022


This is our call to the brightest minds to join us in tackling the growing global threat of antimicrobial resistance using cutting-edge science and innovation. This presents you with an extraordinary opportunity to make an important scientific contribution while training with internationally leading scientists at Oxford and Cambridge. If this initiative excites you then we encourage you to apply – wherever you are!

Please read carefully and note the stages of the process before taking any action.

What does the INEOS Oxbridge Doctoral Initiative offer?

Immersion in both Universities

Although registered in either Oxford or Cambridge as their home base, all students will have ample opportunity to spend periods of time as a visitor in the second University, taking part in ongoing collaborations.

Collaboration

Each project is distinct and unique for that student, but there will be the opportunity to collaborate with other students and projects within the initiative, with the additional possibility of input from industry.

Funding

Our studentships are fully funded for three and a half years, through the generous support of the INEOS Oxford Institute. This funding covers UK/international University of Cambridge & Oxford fees in addition to living costs (stipend), which will be equivalent to the standard Wellcome stipend rate.

Future prospects

By the time you graduate, you will have acquired skills that are in high demand worldwide. This includes expertise in drug discovery, machine learning and analysis of big data. Such skills will support your future ambitions wherever these take you, including academia, pharma and private-sector companies.

What projects are being offered?


A total of six projects are available in this round:

Project: ML-guided fragment-based antibiotic discovery for Mycobacterium tuberculosis
Registered in: University of Cambridge
Primary supervisor: Professor Andres Floto email: arf27@cam.ac.uk. Co-supervisor: Dr Josie Bryant
Collaborators: Professor Chris Schofield (University of Oxford), Professor David Spring (University of Cambridge)

Project: Using cutting-edge biophysics to combat antimicrobial resistance
Registered in: University of Oxford
Primary supervisor: Professor Chris Schofield email: christopher.schofield@chem.ox.ac.uk. Co-supervisor: Professor Fernanda Duarte
Collaborators: Professor David Spring, Professor Tuomas Knowles, Professor Andres Floto (University of Cambridge) and Professor Tim Walsh (University of Oxford)

Project: Structure-based design of new antibiotics
Registered in: University of Oxford
Primary supervisor: Professor Chris Schofield email: christopher.schofield@chem.ox.ac.uk. Co-supervisor: Professor Fernanda Duarte
Collaborators: Professor David Spring, Professor Tuomas Knowles, Professor Andres Floto (University of Cambridge) and Professor Tim Walsh (University of Oxford)

Project: Next generation screening platforms for antimicrobial discovery
Registered in: University of Cambridge
Primary supervisor: Professor Tuomas Knowles email: tpjk2@cam.ac.uk
Collaborators: Professor David Spring, Professor Andres Floto (University of Cambridge), Professor Chris Schofield (University of Oxford)

Project: Understanding the impact of antibiotics on the neonatal/infant microbiome and growth development in LMICs
Registered in: University of Oxford
Primary supervisor: Professor Tim Walsh email: timothy.walsh@zoo.ox.ac.uk. Co-supervisor: Dr Kirsty Sands
Collaborators: Professor Julian Parkhill (University of Cambridge)

Project: Identification of novel antibiotic resistance mechanisms in Klebsiella pneumoniae using machine learning
Registered in: University of Cambridge
Primary supervisor: Professor Julian Parkhill email: jp369@cam.ac.uk. Co-supervisor: Dr Caitlin Collins
Collaborators: Professor Tim Walsh (University of Oxford)

Application process


We are now accepting applications.
Application Deadline: 30 June 2022 at 11:59pm GMT.
Start Date: October 2022.

Step 1: Make initial contact with the primary supervisor of the project you are interested in. Emails details are shown in the project description above.

Step 2: The supervisors will provide further information about the projects and advice on how to submit a formal application to the correct course via the relevant University’s application portal.

If you have any questions about the application process, please contact Joyce Nzekwu: joyce.nzekwu@ineosoxford.ox.ac.uk

Additional information


More information about the different departments and courses can be found below:

University of Oxford:

University of Cambridge:

Learn more

About the IOI

The Ineos Oxford Institute for Antimicrobial Research (IOI) was established at the University of Oxford in January 2021 to advance research, education and collaboration in search of solutions to one of the biggest public health challenges of our time.

Learn More

What is AMR

AMR is one of the most complex and multifaceted health challenges facing the global community today. The next few years will define the trajectory of the long-term global AMR response and how successful it can be. The time to act- to prevent the unthinkable from becoming the inevitable - is now.

Learn More